Carr Edward
- SEC CIK
- 0001273351
In the past year, 2 open-market sale filings worth $5.59M and no purchases.
Current role at each company
- DNTH Dianthus Therapeutics, Inc.CHIEF ACCOUNTING OFFICERas of Sep 18, 2026
- ABEO Abeona Therapeutics Inc.Chief Financial Officeras of Oct 8, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $5.59M
- 2 filings
- Net
- −$5.59M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Carr Edward as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
DNTH Dianthus Therapeutics, Inc.
CHIEF ACCOUNTING OFFICER2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 18, 2026 (view filing)4:36 PM ET | Sep 17 | 1 day | Carr EdwardCHIEF ACCOUNTING OFFICER | SSale | −20.0K | $101.38 | −$2.03M | −100.0%0 after | 5 lots10b5-1 |
| Mar 13, 2026 (view filing) | Mar 12 | 1 day | Carr EdwardCHIEF ACCOUNTING OFFICER | SSale | −43.7K | $81.49 | −$3.56M | −100.0%0 after | 5 lots10b5-1 |
ABEO Abeona Therapeutics Inc.
Chief Financial Officer1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 2021 (view filing) | Oct 8 | Same day | Carr EdwardChief Financial Officer | SSale | −29.1K | $1.05 | −$30.6K | −6.8%400.2K after |